急性髓系白血病合并急性呼吸衰竭入住ICU患者的特征与结局:一项前瞻性多中心研究的事后分析
这是对一项国际多中心前瞻性队列研究的事后分析,对象为入住ICU的免疫功能受损合并急性呼吸衰竭患者,其中201例急性髓系白血病患者纳入分析。院内死亡率为46.8%。与死亡独立相关的因素包括ECOG体能状态≥2(OR=2.79,p=0.04)、咳嗽(OR=2.94,p=0.034)、使用血管升压药(OR=2.79,p=0.044)、白血病特异性肺部受累(即白细胞淤滞、原始细胞肺部浸润或急性溶解性肺病,OR=4.76,p=0.011)及肝脏SOFA评分(OR=1.85,p=0.014);局灶性肺泡型胸部X线表现与生存相关(OR=0.13,p=0.001)。聚类分析识别出3个亚型,其中第2和第3类在多因素分析中与院内死亡独立相关。作者认为这些亚型具有预后意义,可指导临床医生优化管理策略。
要点
- 急性髓系白血病合并急性呼吸衰竭患者院内死亡率为46.8%。
- 白血病特异性肺部受累(白细胞淤滞、原始细胞肺部浸润或急性溶解性肺病)与死亡独立相关(OR=4.76,p=0.011)。
- ECOG体能状态≥2(OR=2.79,p=0.04)、咳嗽(OR=2.94,p=0.034)、使用血管升压药(OR=2.79,p=0.044)及肝脏SOFA评分(OR=1.85,p=0.014)与死亡独立相关。
- 局灶性肺泡型胸部X线表现与生存相关(OR=0.13,p=0.001)。
- 聚类分析识别出3个急性呼吸衰竭亚型(白血病型、肺型、炎症型),其中第2和第3类在多因素分析中与院内死亡独立相关。
适用人群与场景
- 免疫功能受损合并急性呼吸衰竭入住ICU的患者,其中201例急性髓系白血病患者纳入本分析。
研究设计与关键结果
- 研究类型:一项国际多中心前瞻性队列研究的事后分析,研究对象为入住ICU的免疫功能受损合并急性呼吸衰竭患者。
- 样本量:1611例免疫功能受损合并急性呼吸衰竭患者中,201例急性髓系白血病患者纳入分析。
- 主要终点:院内死亡率为46.8%。
- 与死亡独立相关的因素:ECOG体能状态≥2(OR=2.79,p=0.04)、咳嗽(OR=2.94,p=0.034)、使用血管升压药(OR=2.79,p=0.044)、白血病特异性肺部受累(即白细胞淤滞、原始细胞肺部浸润或急性溶解性肺病,OR=4.76,p=0.011)、肝脏SOFA评分(OR=1.85,p=0.014)。
- 与生存相关的因素:局灶性肺泡型胸部X线表现(OR=0.13,p=0.001)。
- 聚类分析识别出3个亚型:白血病型(高危急性髓系白血病患者,孤立性、较轻的急性呼吸衰竭)、肺型(有症状、需高氧、严重急性呼吸衰竭,影像学弥漫性表现,见于重度免疫功能受损患者)、炎症型(除急性呼吸衰竭外合并多器官衰竭)。
- 多因素分析中,第2类和第3类与院内死亡独立相关。
证据类型、等级与局限
- 证据类型:国际多中心前瞻性队列研究的事后分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,急性髓系白血病合并急性呼吸衰竭患者中与不良结局相关的因素涉及患者背景(体能状态、白血病肺部受累)、症状、影像学表现、使用血管升压药的需要及肝脏SOFA评分。
- 作者认为,识别出的三种急性呼吸衰竭亚型具有预后意义,可指导临床医生优化管理策略。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Acute respiratory failure (ARF) is the leading cause of intensive care unit (ICU) admission in patients with Acute Myeloid Leukemia (AML) and data on prognostic factors affecting short-term outcome are needed.
METHODS: This is a post-hoc analysis of a multicenter, international prospective cohort study on immunocompromised patients with ARF admitted to ICU. We evaluated hospital mortality and associated risk factors in patients with AML and ARF; secondly, we aimed to define specific subgroups within our study population through a cluster analysis.
RESULTS: Overall, 201 of 1611 immunocompromised patients with ARF had AML and were included in the analysis. Hospital mortality was 46.8%. Variables independently associated with mortality were ECOG performance status ≥ 2 (OR = 2.79, p = 0.04), cough (OR = 2.94, p = 0.034), use of vasopressors (OR = 2.79, p = 0.044), leukemia-specific pulmonary involvement [namely leukostasis, pulmonary infiltration by blasts or acute lysis pneumopathy (OR = 4.76, p = 0.011)] and liver SOFA score (OR = 1.85, p = 0.014). Focal alveolar chest X-ray pattern was associated with survival (OR = 0.13, p = 0.001). We identified 3 clusters, that we named on the basis of the most frequently clinical, biological and radiological features found in each cluster: a "leukemic cluster", with high-risk AML patients with isolated, milder ARF; a "pulmonary cluster", consisting of symptomatic, highly oxygen-requiring, severe ARF with diffuse radiological findings in heavily immunocompromised patients; a clinical "inflammatory cluster", including patients with multi-organ failures in addition to ARF. When included in the multivariate analysis, cluster 2 and 3 were independently associated with hospital mortality.
CONCLUSIONS: Among AML patients with ARF, factors associated with a worse outcome are related to patient's background (performance status, leukemic pulmonary involvement), symptoms, radiological findings, the need for vasopressors and the liver SOFA score. We identified three specific ARF syndromes in AML patients, which showed a prognostic significance and could guide clinicians to optimize management strategies.
参考来源
- Secreto C, Chean D, van de Louw A, et al. Characteristics and outcomes of patients with acute myeloid leukemia admitted to intensive care unit with acute respiratory failure: a post-hoc analysis of a prospective multicenter study. Ann Intensive Care. 2023. PMID: 37658994. doi:10.1186/s13613-023-01172-3
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。